Physician profile
Poly Chen
NPI 1255421467
$13,661.97
in general payments reported to CMS, 2019-2025
17 companies · $299 in 2025
The $299 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,816 · 2020: $388 · 2021: $3,357 · 2022: $845 · 2023: $592 · 2024: $364 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,255.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stimwave Technologies Incorporated | $7,448.89 | 2019-2022 | |
| Abbott Laboratories | $2,437.19 | 2019-2025 | Proclaim, Eterna, Octrode |
| Spinal Simplicity, LLC | $2,403.48 | 2021-2022 | |
| Abbvie INC. | $283.14 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Curonix LLC | $210.09 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $197.06 | 2019-2021 | |
| Nalu Medical, INC. | $194.61 | 2021 | |
| Vertos Medical, INC. | $97.24 | 2023 | Mild Device Kit |
| Relievant Medsystems, INC. | $90.46 | 2022 | |
| Si-Bone, INC. | $68.09 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $57.15 | 2023-2024 | Iovera |
| Allergan, INC. | $47.11 | 2019-2021 | |
| Grt US Holding, INC. | $37.08 | 2022 | |
| Saluda Medical Americas, INC. | $29.75 | 2025 | Evoke |
| Arbor Pharmaceuticals, INC. | $29.48 | 2020-2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.06 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $15.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Poly Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.